View Older Stories
-
Modular Medical Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule
-
Modular Medical prices $4.68 million public offering at $0.77 per unit
-
Modular Medical Announces Pricing of $4.68 Million Public Offering
-
Modular Medical announces public offering of common stock and warrants
-
Modular Medical Announces Proposed Public Offering
-
Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump
-
Modular Medical submits insulin patch pump for FDA clearance
-
Modular Medical Submits Pivot Tubeless Insulin Patch Pump for FDA 510(k) Clearance
-
Modular Medical validates Pivot controller line for 2026 launch
-
Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System
-
Modular Medical completes stage 1 ISO audit for CE mark certification
-
Modular Medical Announces Ongoing Progress to Obtain CE Mark
-
Modular Medical hires David Bosshard for international expansion
-
Modular Medical Appoints David Bosshard to Lead its International Expansion for the Pivot Insulin Delivery System
-
Modular Medical raises $4.4 million through warrant exercise
-
Modular Medical Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
-
Modular Medical gets IRB approval for Pivot insulin pump feasibility study
-
Modular Medical Receives IRB Approval for Pivot Insulin Delivery System Feasibility Study
-
Modular Medical completes clinical study of MODD1 insulin pump
-
Modular Medical Announces Completion of Clinical Study of MODD1 Pump
-
Modular Medical Announces Completion of MODD1 Cartridge Production and Commencement of Pivot Conversion
-
Modular Medical debuts Pivot insulin pump at ADCES conference
-
Modular Medical Announces Next-Generation Pivot Insulin Pump at ADCES and Introduction of Level Ex Gamified Training Collaboration
-
Modular Medical Announces First Human Use of MODD1 Pump Delivering Insulin
-
Modular Medical Announces MODD1 Cartridge Line Validated for Human-Use Production
-
Modular Medical to Present Data from Study Examining Pump Delivery of a GLP-1R Agonist at the ADA 85th Scientific Sessions
-
Modular Medical (MODD) Appoints Jeff Goldberg to its Board
-
Modular Medical Appoints Industry Veteran Jeff Goldberg to Board of Directors
-
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "Making Diabetes Management Simpler: The New Era of Insulin Therapy" Featuring Modular Medical CEO - Wednesda
-
Modular Medical to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
-
Modular Medical (MODD) Announces $12 Million Private Placement
-
Modular Medical Announces $12 Million Private Placement
-
New to the Street to Broadcast Show 627 on Bloomberg Television at 6:30 PM EST Today as Sponsored Programming
-
New to The Street Premieres Back-to-Back Episodes on Bloomberg: Episode 624 Aired Last Night, Episode 625 Airs Tonight at 6:30 PM EST as Sponsored Programming
-
Modular Medical Announces BSI Group as Trusted Body for CE Mark Clearance
-
New to The Street to Air Sponsored Programming on Bloomberg Television Tonight at 6:30 PM EST Featuring HPB, PillSafe, LightPath Technologies, Modular Medical, and SGTM's Sustainable Green Team
-
Modular Medical (MODD) Announces Licensing and Partnership Agreement With Nudge BG
-
Modular Medical Announces Licensing and Partnership Agreement With Nudge BG
-
New to the Street Show #617 Airs Tonight on Fox Business at 10:30 PM PST as Sponsored Programming
-
Modular Medical Announces Conference Call to Provide Business Update
-
Modular Medical Announces Pricing of $8.2 Million Public Offering
-
Modular Medical Announces Proposed Public Offering
-
Modular Medical Proudly Sponsors the Inaugural Achieving Diabetes Equity in Practice Today (ADEPT) Conference
-
Registration Is Now Open For Tribe Public's Webinar Event "Tailoring GLP-1 Weight Loss Treatments: Innovative Approaches To Personalized Dosing" Featuring Modular Medical CEO On Monday, November 11, 2
-
Modular Medical (MODD) Announces Results from a Successful GLP-1 Proof of Concept Study
-
Modular Medical Announces Results from a Successful GLP-1 Proof of Concept Study
-
New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable G
-
New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical (NASDAQ:MODD), Acurx Pharmaceuticals (NASDAQ:ACXP), and LightPath Technologies (NASDAQ:LPT
-
Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1
-
Modular Medical (MODD) Issued US Patent Covering Key Aspects of Core Pumping Technology

